149 related articles for article (PubMed ID: 20225230)
21. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
[TBL] [Abstract][Full Text] [Related]
22. Quality of life in ovarian cancer patients: comparison of paclitaxel plus cisplatin, with cyclophosphamide plus cisplatin in a randomized study.
Bezjak A; Tu D; Bacon M; Osoba D; Zee B; Stuart G; Roy JA; Piccart M; Eisenhauer E
J Clin Oncol; 2004 Nov; 22(22):4595-603. PubMed ID: 15466785
[TBL] [Abstract][Full Text] [Related]
23. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
Cengiz M; Ozyar E; Esassolak M; Altun M; Akmansu M; Sen M; Uzel O; Yavuz A; Dalmaz G; Uzal C; Hiçsönmez A; Sarihan S; Kaplan B; Atasoy BM; Ulutin C; Abacioğlu U; Demiral AN; Hayran M
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1347-53. PubMed ID: 16169671
[TBL] [Abstract][Full Text] [Related]
24. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel/carboplatin as first-line chemotherapy in advanced ovarian cancer: efficacy and adverse effects with special consideration of peripheral neurotoxicity.
Mayerhofer K; Bodner-Adler B; Bodner K; Leodolter S; Kainz C
Anticancer Res; 2000; 20(5C):4047-50. PubMed ID: 11268499
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for advanced testicular cancer.
Fox EP; Loehrer PJ
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1173-87. PubMed ID: 1723407
[TBL] [Abstract][Full Text] [Related]
27. [Long-term course of blood lipids and body mass index in patients with testicular cancer treated with chemotherapy].
Fernández-Miranda C; Schoebel N; Angulo A; Paz-Ares L; Lianes P; del Palacio A
Rev Clin Esp; 1997 Jul; 197(7):490-3. PubMed ID: 9411545
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
Taphoorn MJ; van den Bent MJ; Mauer ME; Coens C; Delattre JY; Brandes AA; Sillevis Smitt PA; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; Allgeier A; Bottomley A;
J Clin Oncol; 2007 Dec; 25(36):5723-30. PubMed ID: 18089866
[TBL] [Abstract][Full Text] [Related]
29. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
[TBL] [Abstract][Full Text] [Related]
30. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
[TBL] [Abstract][Full Text] [Related]
31. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
32. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
33. Platinum organ toxicity and possible prevention in patients with testicular cancer.
Hartmann JT; Kollmannsberger C; Kanz L; Bokemeyer C
Int J Cancer; 1999 Dec; 83(6):866-9. PubMed ID: 10597214
[TBL] [Abstract][Full Text] [Related]
34. Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.
Haugnes HS; Stenklev NC; Brydøy M; Dahl O; Wilsgaard T; Laukli E; Fosså SD
Acta Oncol; 2018 Aug; 57(8):1075-1083. PubMed ID: 29384420
[TBL] [Abstract][Full Text] [Related]
35. Understanding peripheral neuropathy in patients with cancer: background and patient assessment.
Sweeney CW
Clin J Oncol Nurs; 2002; 6(3):163-6. PubMed ID: 11998611
[TBL] [Abstract][Full Text] [Related]
36. Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot study.
Heier MS; Nilsen T; Graver V; Aass N; Fosså SD
Br J Cancer; 1991 Apr; 63(4):550-2. PubMed ID: 1850610
[TBL] [Abstract][Full Text] [Related]
37. Long-term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin-based chemotherapy for malignant ovarian germ cell tumor.
Solheim O; Skalleberg J; Warncke T; Ørstavik K; Tropé C; Fosså SD
Acta Obstet Gynecol Scand; 2019 Feb; 98(2):240-249. PubMed ID: 30289161
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular risk in testicular cancer survivors treated with chemotherapy: incidence, significance, and practice implications.
Zoltick BH; Jacobs LA; Vaughn DJ
Oncol Nurs Forum; 2005 Sep; 32(5):1005-9; quiz 1010-1. PubMed ID: 16136198
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.
Strumberg D; Brügge S; Korn MW; Koeppen S; Ranft J; Scheiber G; Reiners C; Möckel C; Seeber S; Scheulen ME
Ann Oncol; 2002 Feb; 13(2):229-36. PubMed ID: 11885999
[TBL] [Abstract][Full Text] [Related]
40. [Cardiovascular morbidity in patients after treatment for testicular cancer].
Valentová M; Mladosievicová B
Vnitr Lek; 2010 Sep; 56(9):915-9. PubMed ID: 21137178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
